Literature DB >> 2970141

Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.

C G Orosz1, P W Adams, R M Ferguson.   

Abstract

We have used limiting dilution analysis to study the behavior of alloantigen-reactive cytolytic T lymphocytes derived from human peripheral blood. During these studies, we found that the presence of cyclosporine in limiting dilution microcultures significantly impairs the subsequent development of alloantigen-reactive cytolytic T cell activity. As a result, CsA reduces the estimate of CTL precursor frequency by limiting dilution analysis. CTL frequency estimates are reduced by CsA in a dose-dependent manner, and concentrations of CsA that are readily achieved in human peripheral blood (100-1000 ng/ml) are capable of reducing estimates of CTL frequency by 90% to 100%. Further studies revealed that (1) human CTL derived either from fresh peripheral blood or from primary mixed lymphocyte cultures are sensitive to the suppressive effects of cyclosporine in limiting dilution microcultures, indicating that CsA influences both alloantigen-primed CTL and CTL precursors; (2) CsA impairs an immunologic event or events, that occurs for at least the first four days of limiting dilution microculture incubation; (3) CsA-mediated suppression is eliminated by separation of CTL from cyclosporine; (4) CsA blocks development of CTL generation, but not cell proliferation in limiting dilution microcultures; and (5) the CsA-mediated suppression is not reversed by supraoptimal concentrations of IL-2, high concentrations of gamma-IFN, or supplementation with the multiple lymphokines present in MLC supernatants. These data suggest that CsA may have a direct inhibitory influence on the differentiation of human CTL precursors that is independent of helper T cell dysfunction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970141

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Effect of zidovudine on the primary cytolytic T-lymphocyte response and T-cell effector function.

Authors:  S Francke; C G Orosz; K A Hayes; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals.

Authors:  K A Clouse; P W Adams; C G Orosz
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.

Authors:  Sabine Francke; Charles G Orosz; Jason Hsu; Lawrence E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

5.  Sporotrichoid Skin Infection Caused by Nocardia brasiliensis in a Kidney Transplant Patient.

Authors:  Folusakin Ayoade; Pradeep Mada; Andrew Stevenson Joel Chandranesan; Mohammed Alam
Journal:  Diseases       Date:  2018-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.